Jamie Messer, MD
Urology · Louisville, KYNPI 1316926298
Payments from drug & device makers
Across 74 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$96
- Coloplast$88
- Eisai Inc.$74
- Astellas Pharma US Inc$73
- Rochester Medical Corporation$72
- Sumitomo Pharma America, Inc.$67
- plus $930 from 26 others
What the payments were for
- Food & beverage$1,400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $96 |
| Coloplast | 5 | $88 |
| Eisai Inc. | 4 | $74 |
| Astellas Pharma US Inc | 4 | $73 |
| Rochester Medical Corporation | 3 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| Seagen Inc. | 4 | $66 |
| Merck | 4 | $65 |
| Progenics Pharmaceuticals, Inc. | 3 | $58 |
| Boston Scientific | 1 | $56 |
| Medtronic(2 entities) | 2 | $49 |
| Pfizer | 3 | $47 |
| AstraZeneca | 3 | $47 |
| Sun Pharmaceutical Industries Inc. | 2 | $46 |
| Blue Earth Diagnostics | 2 | $46 |
| Urogen Pharma, Inc. | 3 | $41 |
| Photocure Inc | 2 | $40 |
| AbbVie | 2 | $40 |
| Incyte Corporation | 3 | $36 |
| Foundation Medicine, Inc. | 2 | $34 |
| Intuitive Surgical | 1 | $32 |
| KARL Storz Endoscopy-america | 1 | $31 |
| Procept Biorobotics Corporation | 1 | $30 |
| Bayer | 2 | $28 |
| Clinigen, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Cook Medical LLC | 1 | $18 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $11 |
How this compares
$1,400 in reported general payments places this provider in the 30th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Solifenacin Succinate | 28 | $941 |
| Finasteride | 82 | $717 |
| Tamsulosin Hcl | 80 | $640 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $92 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $29 |
Paid to pharmacies, not to this prescriber.
Other urology in Louisville
- Uzoma AneleLouisville$60K
- Kellen ChoiLouisville$17K
- Rosa ParkLouisville$16K
- Terrance BlackfordLouisville$13K
- Mohammed SaidLouisville$11K
- Jessica SchardeinLouisville$9K
- Jonathan WittenLouisville$9K
- Morris JacksonLouisville$7K
- Patrick HensleyLexington$153K
- Thomas SlabaughLexington$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.